CT Scanning News and Research

RSS

New drug shows promise against treatment-resistant non-small cell lung cancer

A new drug that targets not only common cancer-causing genetic mutations in patients with non-small cell lung cancer (NSCLC), but also a form of the mutation that causes resistance to treatment, has shown promising results in patients in a phase I/II clinical trial.

23 Nov 2014

New course underlines the importance of early detection of lung cancer

In Japan, 40 percent of lung cancer cases are detected on early stages and treated with a high probability of remission; in the US 20 percent of cases have that possibility, while in Mexico, in the National Cancer Institute (INCan), only 1.2 percent of patients are diagnosed at an early stage.

21 Nov 2014

New findings may help develo injury-prevention measures

This week's issue of the New England Journal of Medicine features an article that highlights an unprecedented analysis of the nation's childhood head injuries. The study, authored by

14 Nov 2014

Study offers unprecedented picture of how children frequently suffer head injuries

A study in which more than 43,000 children were evaluated for head trauma offers an unprecedented picture of how children most frequently suffer head injuries, report physicians at Washington University School of Medicine in St. Louis and the University of California, Davis, School of Medicine.

13 Nov 2014

Lung cancer screening in NLST meets standard for cost effectiveness

Dartmouth researchers say lung cancer screening in the National Lung Screening Trial (NLST) meets a commonly accepted standard for cost effectiveness as reported in the Nov. 6 issue of the New England Journal of Medicine. This relatively new screening test uses annual low-dose CT scans to spot lung tumors early in individuals facing the highest risks of lung cancer due to age and smoking history.

11 Nov 2014

Researchers make significant advancement in early diagnosis of invasive cancers

A team of researchers from Inserm led by Paul Hofman (Inserm Unit 1081/University of Nice) has just made a significant advance in the area of early diagnosis of invasive cancers. In a study which has just been published in the journal PLOS ONE, the team shows that it is possible to detect, in patients at risk of developing lung cancer, early signs, in the form of circulating cancer cells, several months, and in some cases several years, before the cancer becomes detectable by CT scanning.

4 Nov 2014

Study estimates Medicare costs of lung cancer diagnostic workup in patients

Biopsies were found to be the most costly tool prescribed in lung cancer diagnosis, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.

31 Oct 2014

Group encourages approval of lung cancer screening for eligible Medicare patients

As the Centers for Medicare & Medicaid Services Committee on Coverage studies the decision to cover lung cancer screening for eligible individuals, today's Online First section of the journal CHEST published Components for High Quality Lung Cancer Screening: American College of Chest Physicians and American Thoracic Society Policy Statement.

31 Oct 2014

UT Southwestern Medical Center unveils new $800 million hospital

UT Southwestern Medical Center will unveil its new $800 million hospital at a dedication ceremony today. The 12-floor, 460-bed facility is being hailed as a patient-centered, state-of-the-art medical innovation for the people of Dallas, North Texas, and beyond.

30 Oct 2014

Bedside ultrasound machine in pediatric ER is cost-effective, reduces length of stay in the ER

Using a portable or bedside ultrasound machine in the pediatric emergency room has been proven to lessen the length of stay in the ER and to provide images equal in accuracy to x-ray or CT scan without exposing children to potentially harmful radiation.

9 Oct 2014

Care lags for people who have stroke in hospital, study finds

At the first sign of a stroke, time is of the essence. For every minute of delay in treatment, people typically lose almost two million brain cells. Yet a new study presented at the Canadian Stroke Congress reveals that those delays - in getting the right tests and the right drugs - can be longer when people experience a stroke in a hospital.

6 Oct 2014

Sanofi, Regeneron report positive Phase 2 study of dupilumab in patients with CSwNP

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that a Phase 2a proof-of-concept study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, met all primary and secondary endpoints in patients with moderate-to-severe chronic sinusitis with nasal polyps (CSwNP) who did not respond to intranasal corticosteroids.

30 Sep 2014

Novel imaging technique could revolutionise diagnosis of neuroblastoma

CANCER RESEARCH UK's Centre for Drug Development, in collaboration with the Rising Tide Foundation, a Swiss-based non-profit organisation which funds innovative cancer trials, today (TUESDAY) announce a new trial at The Royal Marsden and University College London that could revolutionise how children with one of the deadliest forms of cancer are diagnosed.

30 Sep 2014

Enlargement of left atrial appendage may be a risk factor of strokes with cardiac origin: Finnish study

More than half of the patients who have suffered a stroke with no well-defined aetiology have an enlarged left atrial appendage of the heart, according to a Finnish study. The results indicate that the enlargement of the left atrial appendage may be an independent risk factor of strokes with cardiac origin.

25 Sep 2014

PET-CT more accurate than conventional CT in evaluating patients with follicular lymphoma

Positron emission tomography/computed tomography (PET-CT) is more accurate than conventional CT scanning in measuring response to treatment and predicting survival in patients with follicular lymphoma, and should be used routinely in clinical practice, according to new research published in The Lancet Haematology.

19 Sep 2014

3D-printed heart model created by Materialise

Materialise (Nasdaq:MTLS), a pioneer in 3D Printing for medical applications, recently created a 3D-printed heart model for doctors at Cincinnati Children’s Hospital to support Bradley White’s case, a 16-year-old boy who was born with a tumor. With the aid of Materialise’s HeartPrint® 3D-printed model, his doctors were able to determine the best treatment for Bradley’s erratic heartbeat.

From Materialise 17 Sep 2014

CT Scanning News and Research

New drug shows promise against treatment-resistant non-small cell lung cancer

New course underlines the importance of early detection of lung cancer

New findings may help develo injury-prevention measures

Study offers unprecedented picture of how children frequently suffer head injuries

Lung cancer screening in NLST meets standard for cost effectiveness

Researchers make significant advancement in early diagnosis of invasive cancers

Study estimates Medicare costs of lung cancer diagnostic workup in patients

Group encourages approval of lung cancer screening for eligible Medicare patients

UT Southwestern Medical Center unveils new $800 million hospital

Bedside ultrasound machine in pediatric ER is cost-effective, reduces length of stay in the ER

Care lags for people who have stroke in hospital, study finds

Sanofi, Regeneron report positive Phase 2 study of dupilumab in patients with CSwNP

Novel imaging technique could revolutionise diagnosis of neuroblastoma

Enlargement of left atrial appendage may be a risk factor of strokes with cardiac origin: Finnish study

PET-CT more accurate than conventional CT in evaluating patients with follicular lymphoma

3D-printed heart model created by Materialise

Opinions: Controversial view of freedom; a $20,000 CT scan

ESC launches first recommendations on use of all new oral anticoagulants in pulmonary embolism

Current x-ray- examinations capture only 20% of lung cancer cases

New x-ray imaging system helps monitor effectiveness of treatment for cystic fibrosis

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News